Moody Lynn & Lieberson, LLC Abb Vie Inc. Transaction History

Moody Lynn & Lieberson, LLC

$1.54 Billion
Q3 2024

A detailed history of Moody Lynn & Lieberson, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Moody Lynn & Lieberson, LLC holds 181,165 shares of ABBV stock, worth $32.6 Million. This represents 2.32% of its overall portfolio holdings.

Number of Shares

181,165

Previous 155,315 16.64%

Holding current value

$32.6 Million

Previous $26.6 Million 34.3%

% of portfolio

2.32%

Previous 1.81%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$163.84 - $199.33 $4.24 Million - $5.15 Million	25,850 Added 16.64%	181,165 $35.8 Million
Q2 2024 Jul 25, 2024	SELL	$154.79 - $180.76 $2.76 Million - $3.22 Million	-17,823 Reduced 10.29%	155,315 $26.6 Million
Q1 2024 Apr 23, 2024	BUY	$159.82 - $182.1 $11.1 Million - $12.6 Million	69,276 Added 66.7%	173,138 $31.5 Million
Q4 2023 Jan 24, 2024	BUY	$137.6 - $154.97 $70,726 - $79,654	514 Added 0.5%	103,862 $16.1 Million
Q3 2023 Oct 24, 2023	BUY	$133.59 - $154.65 $169,258 - $195,941	1,267 Added 1.24%	103,348 $15.4 Million
Q2 2023 Jul 27, 2023	BUY	$132.51 - $164.9 $595,499 - $741,060	4,494 Added 4.61%	102,081 $13.8 Million
Q1 2023 May 02, 2023	SELL	$144.61 - $166.54 $2.43 Million - $2.79 Million	-16,770 Reduced 14.66%	97,587 $15.6 Million
Q4 2022 Feb 01, 2023	SELL	$138.31 - $165.87 $104,838 - $125,729	-758 Reduced 0.66%	114,357 $18.5 Million
Q3 2022 Oct 26, 2022	SELL	$134.21 - $153.93 $5.29 Million - $6.06 Million	-39,383 Reduced 25.49%	115,115 $15.5 Million
Q2 2022 Jul 28, 2022	SELL	$137.62 - $174.96 $131,702 - $167,436	-957 Reduced 0.62%	154,498 $23.7 Million
Q1 2022 Apr 27, 2022	BUY	$131.98 - $163.75 $2.09 Million - $2.6 Million	15,869 Added 11.37%	155,455 $25.2 Million
Q4 2021 Jan 26, 2022	BUY	$107.43 - $135.93 $14.5 Million - $18.4 Million	135,024 Added 2959.75%	139,586 $18.9 Million
Q3 2021 Oct 26, 2021	BUY	$106.4 - $120.78 $20,748 - $23,552	195 Added 4.47%	4,562 $492,000
Q2 2021 Jul 28, 2021	SELL	$105.21 - $117.21 $4,524 - $5,040	-43 Reduced 0.98%	4,367 $492,000
Q1 2021 Apr 23, 2021	BUY	$102.3 - $112.62 $3,478 - $3,829	34 Added 0.78%	4,410 $477,000
Q4 2020 Jan 26, 2021	BUY	$80.49 - $108.67 $80,490 - $108,670	1,000 Added 29.62%	4,376 $469,000
Q1 2020 Apr 30, 2020	BUY	$64.5 - $97.79 $217,752 - $330,139	3,376 New	3,376 $257,000
Q1 2019 Apr 23, 2019	SELL	$77.14 - $90.79 $179,890 - $211,722	-2,332 Closed	0 $0
Q4 2018 Jan 29, 2019	SELL	$77.85 - $96.01 $58,387 - $72,007	-750 Reduced 24.33%	2,332 $215,000
Q3 2018 Oct 29, 2018	BUY	$88.91 - $98.84 $25,339 - $28,169	285 Added 10.19%	3,082 $291,000
Q2 2018 Jul 24, 2018	SELL	$89.78 - $106.23 $12,389 - $14,659	-138 Reduced 4.7%	2,797 $259,000
Q1 2018 Apr 27, 2018	BUY	$92.01 - $123.21 $12,697 - $17,002	138 Added 4.93%	2,935 $278,000
Q4 2017 Feb 02, 2018	BUY	$89.56 - $98.21 $17,912 - $19,642	200 Added 7.7%	2,797 $324,000
Q3 2017 Nov 06, 2017	BUY	$69.85 - $89.22 $181,400 - $231,704	2,597	2,597 $231,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Lynn & Lieberson, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Lynn & Lieberson, LLC with notifications on news.

Account

Moody Lynn & Lieberson, LLC Abb Vie Inc. Transaction History